Back

Contemporary use of beta-blockers in the outpatient treatment of heart failure with atrial fibrillation

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Optimal framework for heart-failure care Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yoshitaka Iwanaga

National Cerebral & Cardiovascular Center, Suita (Japan)

6 More presentations in this session

Presentation thumbnail
The impact of a dedicated heart failure clinic on patients with heart failure with reduced ejection fraction
Doctor A. Almaghraby (Ras Al Khaimah, AE)
Abstract Slides
Presentation thumbnail
The implementation of modern guideline-directed medical therapy among hospitalized patients with heart failure with reduced ejection fraction: real-world experience from two tertiary cardiac centers
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides
Presentation thumbnail
OptiHeart: determinants and prognostic importance of optimal medical treatment in patients with heart failure discharged from the heart failure clinic
Doctor A. Sharfo (Holbaek, DK)
Abstract Slides
Presentation thumbnail
Time taken for cardiology care and one-year results for primary care physicians' referrals for cardiology consultation in heart failure patients: clinical implications for heart failure management
Mr O. Otero Garcia (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Incidence of 1-year mortality, heart failure admissions and decompensation in patients with heart failure followed in HF units in Spain. Differences according to type of units.
Doctor M. Anguita Gamez (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Optimal framework for heart-failure care

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
thumbnail
Congress Presentation
Is beta- blocker therapy beneficial among patients with heart failure and reduced ejection fraction with concomitant atrial fibrillation rhythm?
thumbnail
Congress Presentation
Influence of persistent atrial fibrillation on the prognosis of heart failure with preserved, mildly reduced, and reduced ejection fraction in women and men.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources